• AAPL 185.1523
  • TSLA 181.18
  • AMZN 186.2
  • MSFT 405.9
  • INTC 30.75
  • EURUSD 1.077
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. MC /
  3. ROVI.MC

Laboratorios Farmaceuticos ROVI (ROVI MC) stock market data APIs

€84.3 2.1(2.6%) as of May 2, 2024

Laboratorios Farmaceuticos ROVI Financial Data Overview

82.2
84.3
-
84.4
81.95
37.96-86.9
4 253 M
25.9531
51 206 K
830 M
0.0157
0.487
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ROVI',
Type: 'Common Stock',
Name: 'Laboratorios Farmaceuticos ROVI',
Exchange: 'MC',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Spain',
CountryISO: 'ES',
OpenFigi: NULL,
ISIN: 'ES0157261019',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '2007-12-05',
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Laboratorios Farmaceuticos ROVI Fundamental Data is available in our Financial Data APIs

  • Net Revenue 830 M
  • EBITDA 244 M
  • Earnings Per Share 3.2
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Laboratorios Farmaceuticos ROVI Earnings via APIs

  • Latest Release 2024-05-08
  • EPS/Forecast NaN

Get Laboratorios Farmaceuticos ROVI End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Laboratorios Farmaceuticos ROVI latest news via APIs

UPDATE 2-Moderna to cut mRNA drug substance production at Lonza facility

(Adds details on production and demand for COVID shots throughout) Sept 19 (Reuters) - Moderna said on Tuesday it will cut production of mRNA drug substance for its COVID-19 vaccine at Lonza's facili...

How Should Investors React To Laboratorios Farmaceuticos Rovi, S.A.'s (BME:ROVI) CEO Pay?

Juan López-Belmonte Encina became the CEO of Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI) in 2017. This report will, first, examine the CEO compensation levels in comparison to CEO compensation a...
  • CEO COMPENSATION
  • JUAN LóPEZ-BELMONTE ENCINA
  • LABORATORIOS FARMACEUTICOS ROVI
  • TOTAL COMPENSATION
Do you have any questions?
support@eodhistoricaldata.com